ALTERNATIVE THERAPY IN SEVERE ASTHMA

[1] Platts-Mills T.A.E., Mitchell E.B., Nock P., Tovey E.R., Moszoro H., Wilkins S.R., Reduction of bronchial hyperreactivity during prolonged allergen avoidance, Lancet, 2, pp. 675-678, (1962)

[2] Van Arsdel P.P., Asthma treatment: a neglected option?, J Allergy Clin Immunol, 67, pp. 348-349, (1981)

[3] Fox J.L., Infectious asthma treated with triacetylean-domycin, Penn Med J, 64, pp. 634-635, (1961)

[4] Itkin I.H., Menzel M., The use of macrolide antibiotic substances in the treatment of asthma, J Allergy, 45, pp. 146-162, (1970)

[5] Spector S.L., Katz F.H., Farr R.S., Troleandomycin: effectiveness in steroid dependent asthma and bronchitis, J Allergy Clin Immunol, 54, pp. 367-379, (1974)

[6] Zeiger R.S., Schatz M., Sperling W., Simon R.A., Stevenson D.D., Efficacy of troleandomycin in outpatients with severe corticosteroid-dependent asthma, J Allergy Clin Immunol, 66, pp. 438-446, (1980)

[7] Wald J.A., Friedman B.F., Farr R.S., An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma, J Allergy Clin Immunol, 78, pp. 36-43, (1986)

[8] Kamada A.R., Hill M.R., Brenner A.M., Szefler S.J., Inhibition of theophylline clearance by troleandomycin: Clinical impact in severe asthmatics (abstr), Pharmacotherapy, 10, (1990)

[9] Suez D., Szefler S.J., Excessive accumulation of mucus in children with asthma: A potential role for erythromycin? A case discussion, J Allergy Clin Immunol, 77, pp. 330-334, (1986)

[10] Szefler S.J., Rose J.Q., Ellis E.F., Spector S.L., Green A.W., Jusko W.J., The effect of troleandomycin on methyl-prednisolone elimination, J Allergy Clin Immunol, 66, pp. 447-451, (1980)

[1] Platts-Mills T.A.E., Mitchell E.B., Nock P., Tovey E.R., Moszoro H., Wilkins S.R., Reduction of bronchial hyperreactivity during prolonged allergen avoidance, Lancet, 2, pp. 675-678, (1962)

[2] Van Arsdel P.P., Asthma treatment: a neglected option?, J Allergy Clin Immunol, 67, pp. 348-349, (1981)

[3] Fox J.L., Infectious asthma treated with triacetylean-domycin, Penn Med J, 64, pp. 634-635, (1961)

[4] Itkin I.H., Menzel M., The use of macrolide antibiotic substances in the treatment of asthma, J Allergy, 45, pp. 146-162, (1970)

[5] Spector S.L., Katz F.H., Farr R.S., Troleandomycin: effectiveness in steroid dependent asthma and bronchitis, J Allergy Clin Immunol, 54, pp. 367-379, (1974)

[6] Zeiger R.S., Schatz M., Sperling W., Simon R.A., Stevenson D.D., Efficacy of troleandomycin in outpatients with severe corticosteroid-dependent asthma, J Allergy Clin Immunol, 66, pp. 438-446, (1980)

[7] Wald J.A., Friedman B.F., Farr R.S., An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma, J Allergy Clin Immunol, 78, pp. 36-43, (1986)

[8] Kamada A.R., Hill M.R., Brenner A.M., Szefler S.J., Inhibition of theophylline clearance by troleandomycin: Clinical impact in severe asthmatics (abstr), Pharmacotherapy, 10, (1990)

[9] Suez D., Szefler S.J., Excessive accumulation of mucus in children with asthma: A potential role for erythromycin? A case discussion, J Allergy Clin Immunol, 77, pp. 330-334, (1986)

[10] Szefler S.J., Rose J.Q., Ellis E.F., Spector S.L., Green A.W., Jusko W.J., The effect of troleandomycin on methyl-prednisolone elimination, J Allergy Clin Immunol, 66, pp. 447-451, (1980)